Tag

Progressive Ms

All articles tagged with #progressive ms

"EMBOLD Study: New Data on 90+ MS Patients Expected in November"

Originally Published 2 years ago — by Multiple Sclerosis News Today

Featured image for "EMBOLD Study: New Data on 90+ MS Patients Expected in November"
Source: Multiple Sclerosis News Today

Atara Biotherapeutics plans to announce in November the one-year data from its EMBOLD Phase 1/2 study, which is testing the experimental treatment ATA188 for progressive forms of multiple sclerosis (MS). The data will cover the trial's primary endpoint of confirmed easing of disease-related disability, as well as other secondary clinical endpoints. ATA188 is designed to fight cells infected by the Epstein-Barr virus (EBV), a leading environmental risk factor for developing MS. The therapy uses immune T-cells obtained from healthy donors to target and attack EBV-infected immune cells in MS patients.

"Ocrevus Outshines Competitors as Top Antibody Therapy for Progressive MS: Review"

Originally Published 2 years ago — by Multiple Sclerosis News Today

Featured image for "Ocrevus Outshines Competitors as Top Antibody Therapy for Progressive MS: Review"
Source: Multiple Sclerosis News Today

Ocrevus (ocrelizumab) is the most effective antibody-based therapy for primary progressive multiple sclerosis (PPMS), according to a review study. The medication reduces disability progression, decreases the risk of needing a wheelchair, and improves upper extremity impairment. However, Ocrevus is associated with an increased risk of infection. The other antibody therapies assessed in the study, including rituximab, Tysabri, and Lemtrada, showed conflicting outcomes and were not as effective in treating PPMS. Further research is needed to fully understand the risks and benefits of these treatments for progressive forms of multiple sclerosis.